PTN - Palatin Technologies Inc. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : PTN - Palatin Technologies Inc.

PTN 14.71

-8.1%

Dec 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (45)	6/7/2001 10:31:05 AM
From: scaram(o)uche	Read Replies (1) of 142

141 phase IIa projected for completion by end of Q3 or beginning of Q4. Partner plans...... soon after phase IIa results are in. Half life is approximately five hours, dose response was observed in the monkeys (but only two doses were studied). One or two new compounds expected to transition into clinical development in the next couple of quarters. Realistically, no technical issues with Leu=Tech production. Control points in mfg. were issue. Now beginning to address FDA issues. Takes four to six months to mfg. a new lot of product. Competitive Technologies royalty is "very low single digits". Sorry, very busy this morning. Could only listen to parts. Call is ongoing at this moment.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next